Literature DB >> 31388108

De novo AFF3 variant in a patient with mesomelic dysplasia with foot malformation.

Daisuke Shimizu1, Rieko Sakamoto2, Kaori Yamoto1, Hirotomo Saitsu3, Maki Fukami4, Gen Nishimura5, Tsutomu Ogata6.   

Abstract

Mesomelic dysplasia (MD) encompasses a heterogeneous group of disorders characterized by shortening of the middle segments of the limbs. Previous studies have revealed the development of Nievergelt type-like MD accompanied by postaxial toe reduction in a patient with a ~500 kb microdeletion at 2q11.2 involving AFF3 alone, and the occurrence of Nievergelt type-like MD in mice with a ~353 kb deletion involving Aff3, together with strong expression of mouse Aff3 in the developing limbs and zeugopod. We encountered a 2 6/12-year-old Japanese girl with an unclassifiable MD associated with hypoplasia of postaxial toes, and identified a de novo likely pathogenic variant of AFF3 (NM_002285.2:c.697 G > A, p.(Ala233Thr)) by whole exome sequencing. The results provide further evidence for AFF3 being the causative gene for MD with foot malformation which may be termed "AFF3-related MD" or "Steichen-Gersdorf type MD".

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31388108     DOI: 10.1038/s10038-019-0650-0

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  16 in total

1.  New mesomelic dysplasia with absent fibulae and triangular tibiae.

Authors:  R Savarirayan; V Cormier-Daire; C J Curry; M B Nashelsky; V Rappaport; D L Rimoin; R S Lachman
Journal:  Am J Med Genet       Date:  2000-09-04

2.  A family with an autosomal dominant mesomelic dysplasia resembling mesomelic dysplasia Savarirayan and Nievergelt types.

Authors:  Mihoko Nakamura; Yukihisa Matsuda; Masaru Higo; Gen Nishimura
Journal:  Am J Med Genet A       Date:  2007-09-01       Impact factor: 2.802

3.  Nosology and classification of genetic skeletal disorders: 2015 revision.

Authors:  Luisa Bonafe; Valerie Cormier-Daire; Christine Hall; Ralph Lachman; Geert Mortier; Stefan Mundlos; Gen Nishimura; Luca Sangiorgi; Ravi Savarirayan; David Sillence; Jürgen Spranger; Andrea Superti-Furga; Matthew Warman; Sheila Unger
Journal:  Am J Med Genet A       Date:  2015-09-23       Impact factor: 2.802

4.  A dominant mesomelic dysplasia associated with a 1.0-Mb microduplication of HOXD gene cluster at 2q31.1.

Authors:  Tae-Joon Cho; Ok-Hwa Kim; In Ho Choi; Gen Nishimura; Andrea Superti-Furga; Kang Suhp Kim; Young-Ju Lee; Woong-Yang Park
Journal:  J Med Genet       Date:  2010-06-24       Impact factor: 6.318

5.  Alice Vance ("Das Bärenweib"): a historical case of Nievergelt syndrome.

Authors:  M Urban; S Krüger
Journal:  Am J Med Genet       Date:  1998-03-05

6.  Mesomelia-synostoses syndrome results from deletion of SULF1 and SLCO5A1 genes at 8q13.

Authors:  Bertrand Isidor; Olivier Pichon; Richard Redon; Debra Day-Salvatore; Antoine Hamel; Karolina A Siwicka; Maria Bitner-Glindzicz; Dominique Heymann; Lena Kjellén; Cornelia Kraus; Jules G Leroy; Geert R Mortier; Anita Rauch; Alain Verloes; Albert David; Cédric Le Caignec
Journal:  Am J Hum Genet       Date:  2010-06-17       Impact factor: 11.025

7.  Patient with the mesomelic dysplasia, Nievergelt syndrome, and cerebellovermian agenesis and cataracts.

Authors:  Beyhan Tüysüz; Cenap Zeybek; Gazi Zorer; Ozlem Sipahi; Savas Ungür
Journal:  Am J Med Genet       Date:  2002-05-01

8.  Mapping autosomal recessive intellectual disability: combined microarray and exome sequencing identifies 26 novel candidate genes in 192 consanguineous families.

Authors:  R Harripaul; N Vasli; A Mikhailov; M A Rafiq; K Mittal; C Windpassinger; T I Sheikh; A Noor; H Mahmood; S Downey; M Johnson; K Vleuten; L Bell; M Ilyas; F S Khan; V Khan; M Moradi; M Ayaz; F Naeem; A Heidari; I Ahmed; S Ghadami; Z Agha; S Zeinali; R Qamar; H Mozhdehipanah; P John; A Mir; M Ansar; L French; M Ayub; J B Vincent
Journal:  Mol Psychiatry       Date:  2017-04-11       Impact factor: 15.992

9.  Laf4/Aff3, a gene involved in intellectual disability, is required for cellular migration in the mouse cerebral cortex.

Authors:  Justin M Moore; Peter L Oliver; Mattéa J Finelli; Sheena Lee; Tom Lickiss; Zoltán Molnár; Kay E Davies
Journal:  PLoS One       Date:  2014-08-27       Impact factor: 3.240

10.  GATA4 variant identified by whole-exome sequencing in a Japanese family with atrial septal defect: Implications for male sex development.

Authors:  Daisuke Shimizu; Satoru Iwashima; Keisuke Sato; Satoshi Hayano; Maki Fukami; Hirotomo Saitsu; Tsutomu Ogata
Journal:  Clin Case Rep       Date:  2018-10-11
View more
  2 in total

1.  Variants in the degron of AFF3 are associated with intellectual disability, mesomelic dysplasia, horseshoe kidney, and epileptic encephalopathy.

Authors:  Norine Voisin; Rhonda E Schnur; Sofia Douzgou; Susan M Hiatt; Cecilie F Rustad; Natasha J Brown; Dawn L Earl; Boris Keren; Olga Levchenko; Sinje Geuer; Sarah Verheyen; Diana Johnson; Yuri A Zarate; Miroslava Hančárová; David J Amor; E Martina Bebin; Jasmin Blatterer; Alfredo Brusco; Gerarda Cappuccio; Joel Charrow; Nicolas Chatron; Gregory M Cooper; Thomas Courtin; Elena Dadali; Julien Delafontaine; Ennio Del Giudice; Martine Doco; Ganka Douglas; Astrid Eisenkölbl; Tara Funari; Giuliana Giannuzzi; Ursula Gruber-Sedlmayr; Nicolas Guex; Delphine Heron; Øystein L Holla; Anna C E Hurst; Jane Juusola; David Kronn; Alexander Lavrov; Crystle Lee; Séverine Lorrain; Else Merckoll; Anna Mikhaleva; Jennifer Norman; Sylvain Pradervand; Darina Prchalová; Lindsay Rhodes; Victoria R Sanders; Zdeněk Sedláček; Heidelis A Seebacher; Elizabeth A Sellars; Fabio Sirchia; Toshiki Takenouchi; Akemi J Tanaka; Heidi Taska-Tench; Elin Tønne; Kristian Tveten; Giuseppina Vitiello; Markéta Vlčková; Tomoko Uehara; Caroline Nava; Binnaz Yalcin; Kenjiro Kosaki; Dian Donnai; Stefan Mundlos; Nicola Brunetti-Pierri; Wendy K Chung; Alexandre Reymond
Journal:  Am J Hum Genet       Date:  2021-05-06       Impact factor: 11.025

Review 2.  Transcription Pause and Escape in Neurodevelopmental Disorders.

Authors:  Kristel N Eigenhuis; Hedda B Somsen; Debbie L C van den Berg
Journal:  Front Neurosci       Date:  2022-05-09       Impact factor: 5.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.